Spontaneous mutations conferring antibiotic resistance to antitubercular drugs at a range of concentrations in Mycobacterium smegmatis.
Drug Dev Res
; 80(1): 147-154, 2019 02.
Article
em En
| MEDLINE
| ID: mdl-30511362
Mycobacteria populations can undergo mutations in their DNA sequence during replication, which if not repaired would be transferred to future generations. Earlier studies have tackled the estimation of mutation rate in mycobacteria at fixed concentrations. However, in this study, in vitro spontaneous mutations in Mycobacterium smegmatis (Msm) mc2 155 (Msm) that confers resistance to some of the most important antitubercular drugs; isoniazid (INHr ), rifampicin (RIFr ), kanamycin (KANr ) and streptomycin (STRr ) were first determined at several highly lethal concentrations, a few of which have not been previously investigated, in a fluctuation assay. Thereafter, mutation rate was estimated using the most commonly adopted Po method, and estimates were then compared concurrently with the Lea-Coulson method of the median and Ma-Sandri-Sarkar Maximum Likelihood Estimator method available on the Fluctuation AnaLysis CalculatOR (FALCOR). The mutation rates of RIFr ranged from 9.24 × 10-8 to 2.18 × 10-10 , INHr 1.2 × 10-7 -1.20 × 10-9 , STRr 2.77 × 10-8 -5.31 × 10-8 and KANr 1.7 × 10-8 mutations per cell division. Data obtained in this study provide mutation rate estimates to key antitubercular drugs at a range of concentrations while also validating a number of the frequent approaches for estimating mutation rates.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Resistência Microbiana a Medicamentos
/
Mycobacterium smegmatis
/
Mutação
/
Antituberculosos
Limite:
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article